Trials / Completed
CompletedNCT01930396
Use of Tinzaparin for Anticoagulation in Hemodialysis
Intermittent HEMOdialysis Anticoagulation With TINzaparin Versus Unfractionated Heparin: A Pilot Multicentre Randomized Controlled Trial (HEMO-TIN Trial)
- Status
- Completed
- Phase
- Phase 4
- Study type
- Interventional
- Enrollment
- 191 (actual)
- Sponsor
- Christine Ribic · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The HEMO-TIN trial is designed to look at both the safety (bleeding risk) and effectiveness (clotting risk) of tinzaparin compared with unfractionated heparin for anticoagulation in hemodialysis patients.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Tinzaparin | |
| DRUG | Unfractionated Heparin | |
| DRUG | Placebo (for Tinzaparin) | 0.9% Normal Saline |
| DRUG | Placebo (for Unfractionated Heparin) | 0.9% Normal Saline |
Timeline
- Start date
- 2013-09-01
- Primary completion
- 2016-09-01
- Completion
- 2016-09-01
- First posted
- 2013-08-28
- Last updated
- 2016-10-14
Locations
1 site across 1 country: Canada
Source: ClinicalTrials.gov record NCT01930396. Inclusion in this directory is not an endorsement.